Click on the table number of the exhibitor to see where they are located on the floor plan

Exhibitor List Index

 

COMPANY NAME BOOTH# Enhanced
Advanced Accelerator Applications 12
AIQ Solutions 32
American Society for Radiation Oncology 43 Upgraded
American Society of Clinical Oncology (ASCO) 36 Upgraded
American Society of Clinical Oncology (ASCO) 35 Upgraded
Astellas Pharma US, Inc. 41
Astellas Pharma US, Inc. 31
Astellas Pharma US, Inc. MR10
AstraZeneca MR14
AstraZeneca MR6
AstraZeneca MR15
AstraZeneca 19
AstraZeneca 4
AstraZeneca 1 Upgraded
Bayer 48
Bayer 25
Blue Earth Diagnostics, Inc. 46
Bristol Myers Squibb 62
Bristol Myers Squibb 39
Calithera Biosciences 20
Canadian Urological Association 47
Caris Life Sciences 22 Upgraded
Clinigen Group 8
Clovis Oncology, Inc. 34
Dendreon Pharmaceuticals LLC MR19
Dendreon Pharmaceuticals LLC 57
Dendreon Pharmaceuticals LLC 53 Upgraded
Eisai Inc. 51
Eisai Inc. 24
Exact Sciences 15
Exelixis, Inc. MR3
Exelixis, Inc. MR18
Exelixis, Inc. MR2
Exelixis, Inc. 64
Exelixis, Inc. 3 Upgraded
FerGene MR1
FerGene 28
Ferring 29
Foundation Medicine, Inc. 16 Upgraded
Genentech 49 Upgraded
Genentech 30
Harborside 55 Upgraded
Haymarket Oncology 21
Immunomedics 27
Incyte Corporation 42
International Kidney Cancer Coalition (IKCC) 37
Invitae Corporation 65
Janssen Biotech, Inc. MR8
Janssen Biotech, Inc. MR7
Janssen Biotech, Inc. MR13
Janssen Biotech, Inc. 45
Janssen Biotech, Inc. 23
Kidney Cancer Association 40
Lightspeed Microscopy, Inc. 7
MDxHealth, Inc. 54
Merck & Co., Inc. 26
Merck & Co., Inc. 2
Merck & Co., Inc. MR9
Merck & Co., Inc. MR12
Merck MRL 2 MR5
Merck MRL 3 MR16
MERCK Pfizer Alliance MR4
MERCK Pfizer Alliance 18
MJH Life Sciences 9
Myriad Genetic Laboratories 6
Nektar Therapeutics 66
Novartis 63
Pacific Edge Diagnostics 50
Pfizer MR17
Pfizer 33
Pfizer 17
Progenics Pharmaceuticals 5
QED Therapeutics, a BridgeBio company 38 Upgraded
Sanofi 11
Sanofi MR11
Seagen Inc. MR20
Seagen Inc. 14 Upgraded
Seagen Inc. 10
Society of Urologic Oncology 44 Upgraded
Sun Pharmaceutical Industries, Inc. 13
Tempus 52